ARMP - Armata Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARMP is currently covered by 1 analysts with an average price target of $15. This is a potential upside of $11.22 (296.83%) from yesterday's end of day stock price of $3.78.

Armata Pharmaceuticals's activity chart (see below) currently has 14 price targets and 18 ratings on display. The stock rating distribution of ARMP is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 92.67% with an average time for these price targets to be met of 1241 days.

Highest price target for ARMP is $15, Lowest price target is $15, average price target is $15.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT. First documented stock forecast 31-Oct-2019.

Best performing analysts who are covering ARMP - Armata Pharmaceuticals:

Joseph Pantginis Jason Mccarthy

Currently out of the existing stock ratings of ARMP, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 31-Oct-2019

$15

$11.26 (301.07%)

$15

Buy Since 06-Feb-2020

$8

$4.26 (113.90%)

6 years 7 months 23 days ago
(06-Feb-2020)

1/1 (100%)

$4.39 (121.61%)

2190

Show more analysts

Please expand the browser size to see the chart

What is ARMP (Armata Pharmaceuticals) average time for price targets to be met?

On average it took 1,241 days for the stock forecasts to be reached, with an average price target met ratio of 92.67%.

Which analyst most recently updated their price target on ARMP (Armata Pharmaceuticals)?

Joseph Pantginis

Which analyst has the current lower performing score on ARMP (Armata Pharmaceuticals) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on ARMP (Armata Pharmaceuticals)?

Joseph Pantginis has 37 price targets and 32 ratings on ARMP

Which analyst is the currently most bullish on ARMP (Armata Pharmaceuticals)?

Joseph Pantginis with the highest potential upside of $11.26

Which analyst is the currently most reserved on ARMP (Armata Pharmaceuticals)?

Jason Mccarthy with the lowest potential downside of $4.26
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?